These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21699833)

  • 1. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS.
    Daoud EG; Glotzer TV; Wyse DG; Ezekowitz MD; Hilker C; Koehler J; Ziegler PD;
    Heart Rhythm; 2011 Sep; 8(9):1416-23. PubMed ID: 21699833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
    J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and stroke: it's not necessarily all about the rhythm.
    Piccini JP; Daubert JP
    Heart Rhythm; 2011 Sep; 8(9):1424-5. PubMed ID: 21699847
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Ezekowitz MD; Hilker C; Miller C; Qi D; Ziegler PD
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):474-80. PubMed ID: 19843914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial tachyarrhythmias temporally precede fluid accumulation in implantable device patients.
    Andriulli JA; Moore HJ; Hettrick DA; Ousdigian KT; Johnson J; Markowitz SM
    Pacing Clin Electrophysiol; 2014 May; 37(5):554-61. PubMed ID: 24341570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators.
    Santini M; Gasparini M; Landolina M; Lunati M; Proclemer A; Padeletti L; Catanzariti D; Molon G; Botto GL; La Rocca L; Grammatico A; Boriani G;
    J Am Coll Cardiol; 2011 Jan; 57(2):167-72. PubMed ID: 21211688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical atrial fibrillation and the risk of stroke.
    Healey JS; Connolly SJ; Gold MR; Israel CW; Van Gelder IC; Capucci A; Lau CP; Fain E; Yang S; Bailleul C; Morillo CA; Carlson M; Themeles E; Kaufman ES; Hohnloser SH;
    N Engl J Med; 2012 Jan; 366(2):120-9. PubMed ID: 22236222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial pacing therapies for prevention of atrial fibrillation in patients with implantable defibrillators.
    Gillis AM
    Card Electrophysiol Rev; 2003 Dec; 7(4):345-7. PubMed ID: 15071250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
    Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
    Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices.
    Turakhia MP; Ziegler PD; Schmitt SK; Chang Y; Fan J; Than CT; Keung EK; Singer DE
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1040-7. PubMed ID: 26175528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Solari D; Bertero E; Miceli R; Brunelli C; Ameri P; Canepa M
    Int J Cardiol; 2017 Jun; 236():262-269. PubMed ID: 28143653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome.
    Willems R; Morck ML; Exner DV; Rose SM; Gillis AM
    Heart Rhythm; 2004 Oct; 1(4):414-21. PubMed ID: 15851193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual atrial tachyarrhythmia burden determined by device interrogation in patients with cardiac implanted electronic devices is associated with a risk of ischaemic stroke independent of known risk factors.
    Wang SH; Kang YC; Wang CC; Wen MS; Hung KC; Wang CY; Chen TH
    Eur J Cardiothorac Surg; 2015 May; 47(5):840-6. PubMed ID: 24970573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.